Peripheral neuropathy Board decisions

The Board remands the claims for an increased rating for hypothyroidism and entitlement to TDIU due to inadequate examination reports.

The Board granted an earlier effective date of February 17, 2021, for the award of increased disability ratings of 20 percent for peripheral neuropathy in both lower extremities but denied increased ratings and other claims.

The Board remanded the appeal for further development and adjudication of higher ratings and effective dates for various peripheral neuropathies associated with NHL, as well as an earlier effective date for a TDIU rating.

The Board denied the Veteran's claim for service connection for peripheral neuropathy of the left upper extremity, finding no current disability. The claim for service connection for left elbow lateral epicondylitis with tendinitis was remanded for further development.

The Board granted an earlier effective date of February 17, 2021, for the award of increased disability ratings of 20 percent for peripheral neuropathy in both lower extremities but denied increased ratings and other claims.

The Board granted service connection for left knee meniscal tear, right knee osteoarthritis, and persistent depressive disorder with anxious distress secondary to service-connected hypothyroidism. The claims for peripheral neuropathy of the lower extremities were denied.

The Board granted a 30 percent rating for diabetic peripheral neuropathy in the left and right lower extremities but denied higher ratings for diabetic nephropathy, diabetes mellitus type II, and other claims.

The Board granted an effective date of September 6, 2023, for the grant of service connection for right and left upper extremity diabetic peripheral neuropathy.

The Board remands the claims for a higher rating of PTSD and service connection for various peripheral neuropathies, lipomas, and chloracne due to inadequate medical examinations.

The Board remands the Veteran's claims for service connection for peripheral neuropathy in all extremities due to a lack of compliance with previous remand directives.

The Board granted service connection for coronary artery disease, diabetes mellitus type 2, bilateral lower extremity peripheral neuropathy (secondary to diabetes), sleep apnea, and a back disability.

The appeal was dismissed as a timely substantive appeal to the October 2017 rating decision was not received.

The Veteran's peripheral neuropathy of the left and right lower extremities, sciatic nerve was granted a rating of 40 percent prior to October 2, 2023, but denied an increased rating from that date. The Veteran was also granted TDIU and DEA benefits.

The appeal regarding service connection for an acquired psychiatric disorder was dismissed, but the Veteran's claims for direct service connection for chronic inflammatory demyelinating polyneuropathy and an initial 10 percent rating for hypertension were granted. The claim for service connection for GERD was remanded.

The Board granted earlier effective dates for the increased ratings of peripheral neuropathy in all extremities and an earlier effective date for TDIU and DEA benefits.

The Board granted an earlier effective date of February 17, 2021, for the award of increased disability ratings of 20 percent for peripheral neuropathy in both lower extremities but denied increased ratings and other claims.

The Board granted increased ratings for neuropathy of the right and left lower sciatic nerves, but denied service connection for bilateral hearing loss, depleted lung function, hypertension, blurred vision, and coronary artery disease.

The Board remands the claims for service connection for diabetes mellitus and bilateral lower extremity diabetic neuropathy due to an inadequate VA opinion.

The Board granted earlier effective dates for the grant of service connection for depression, left ankle disability, and right ankle disability, but denied an earlier effective date for peripheral neuropathy of the bilateral lower extremity.

The Board denied service connection for a lumbar disability and denied increased ratings for various disabilities, except for granting a 60 percent rating for coronary artery disease and a 50 percent rating for PTSD.